Bone Marrow Conventional Karyotyping and Fluorescence In Situ Hybridization: Defining an Effective Utilization Strategy for Evaluation of Myelodysplastic Syndromes.
暂无分享，去创建一个
A. Tefferi | R. Ketterling | C. Hanson | D. V. Van Dyke | M. Patnaik | Paul J. Kurtin | R. He | A. Wiktor | David K Durnick